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EVIDENCE THAT POTASSIUM DEFICIENCY INDUCES GROWTH RETARDATION THROUGH REDUCED SOMATOMEDIN C PRODUC-TION. Growth r e t a r d a t i o n and impaired p r o t e i n s y n t h e s i s a r e major c h a r a c t e r i s t i c s i n potassium (K) d e p l e t i o n i n animals and man.
A f t e r K-repletion serum and muscle c o n t e n t s o f K a r e normalized w i t h i n few hours, while p r o t e i n s y n t h e s i s o n l y reach c o n t r o l l e v e l s w i t h i n days. I n t h e p r e s e n t s t u d y we measured somatomedin C l e v e l s d u r i n g K d e p l e t i o n ( f o d d e r c o n t a i n i n g 1 mmol/kg) and r e p l e t i o n i n young r a t s ( 4 weeks old). Weight g a i n d u r i n g Kd e p l e t i o n f o r 2 weeks was 3.5 t 2.3 g (SD) and i n c o n t r o l s 8 3 t 5 g (P < 10-8). Weight g a i f i f t e r K-repletion f o r 24 and 72 hours was 9 + 2 g and 1 9 + 9 g r e s p e c t i v e l y ( p < 10-3 and P < 10-2). Serum somatomedin C i n K-depleted r a t s was 8 3 + 50 ug/l (SD) versus 1035 + 112 ug/l i n c o n t r o l s (P < 10-8). 6 u r i n g Kr e p l e t i o n f o r 24 and 72 hours serum somatomedin C i n c r e a s e d t o 403 t 7 3 ug/l and 423 + 120 ug/l r e s p e c t i v e l y (P < and p < 10-37. . . , -In conclusion K d e f i c i e n c y i n young r a t s induces growth r e t a r d at i o n and a concomitant pronounced d e c r e a s e i n c i r c u l a t i n g somatomedin C. These changes a r e promptly r e v e r s i b l e f o l l o w i n g Kr e p l e t i o n w i t h i n t h e f i r s t 24 hours. These f i n d i n g s demonstrate t h a t t h e a v a i l a b i l i t y o f K is e s s e n t i a l f o r normal somatomedin C s y n t h e s i s and growth. A. S i l b e r g e l d q , L. Lazar*, R. E s h e t , 2. Dux*, B. Klingcr*, B. E r s t c r * , R. Keret*, C. Elberg*, 2. Laron. I n s t . P e d i a t . & Adolesc. Endocrinol., B c i l i n s o n Med.
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SERUM GROWTll HORMONE BINDING PROTEIN (Ctl-BP) IN PRE-PUBERTAL CHILDREN IS CORRELATED WIT11 HEICIIT. Recently serum CII-BP has been shown t o have i d e n t i c a l N-tcrrninal amino a c i d sequence a s t h e t i s s u e hCIi r e c e p t o r . Serum hCll l e v e l s and t h e s p e c i f i c binding a c t i v i t y o l GtI-BP (expressed a s % of CII-BP a c t i v i t y o f an a d u l t r e
f e r e n c e serum = RSCII-BP) were e s t imated in 25 p r e p u b e r t a l c h i l d r e n ( 1 9 M , 6 F, aged 6-11 y r s ) . When t h e r e s u l t s were r e l a t e d t o h e i g h t , 3 groups could be d i s t i n g u i s h c f . Mean + SD * I vs. TI p < 0.025; I vs. 111 p < < 0.001 I t i s e v i d e n t t h a t GH-BP l e v e l s i n c h i l d r e n s i g n i f i c a n t l y c o r r el a t e d (~0 . 8 3 , p <<0.001) w i t h h e i g h t SDS, but n o t with b a s a l hCll l e v e l s o r age. I t i s t h e r e f o r e p o s s i b l e t h a t GH-BP p r e s e n t s a simple non-invasive t o o l t o determine growth hormone a c t i v i t y . Growth hormone profiles in GH-deficient children on and off twice daily sc GHRII therapy and during a sc infusion of GHKH.
We have previously shown that twice daily sc GHRH therapy promotes growth in GH-deficient children (Lancet 1987; i:S-8) . however this is not an optimal method of administering GHRH and the development of a long-acting preparation would be much more satisfactory. To investigate this possibility we have studied GI3 profiles during twice daily GHRH treatment and the sc infusion of GHRH. 4 children who grew on tWrCe daily sc GHRH therapy (500ug) had 24-hour GH profiles (15min sampling) whilst on treatment and in I before therapy and in the others one month after finishing treatment. Two children have had overnight G H profiles (20niin sampling) during sc infusion of two doses of GHRH (5 daily GHRH increases pulse amplitude and AUC for G H but not always pulse frequency. a similar effect is seen during the sc infusion of GHRH. These resula suggest that a depot preparation of GllRlI delivering 5ug/kg/hr would promote pulsatile G H release. We h a v e a s s e s s e d t h e half-life of e n d o g e n o u s GI1 in 8 normal a d u l t s b y m e a s u r i n g t h e d e c l i n e of CH c o n c e n t r a t i o n s in v e n o u s blood t a k e n a t 10 minute i n t e r v a l s following stimulation b y b o l u s i n t r a v e n o u s injection of GHRH followed b y a n infusion Of somatostatin-14 ( 3 j~g I k g l m i n ) o v e r 120 minutes. T h e half-life of CH (18.24 min) w a s calculated from n a t u r a l log t r a n s f o r m e d d a t a , t h e d e c l i n e b e i n g d e s c r i b e d b y a simple exponential c o n s i s t e n t with a s i n g l e pool model.
CkI d e l i v e r y r a t e from t h e p i t u i t a r y g l a n d w a s calculated b y deconvolution u s i n g t h e estimate of t h e e n d o g e n o u s half-life a n d 24 h r CH profiles in 1 6 p r e p u b e r t a l a n d 12 p u b e r t a l c h i l d r e n .
CH p r o d u c t i o n was negligible a t t h e e n d of e a c h s e c r e t o r y c y c l e , a n 'on-off' phenomenon.
CH s e c r e t i o n r a t e was relatively c o n s t a n t f o r s i z e d u r i n g childhood b u t a 3-4 fold i n c r e a s e w a s d e m o n s t r a t e d d u r i n g p u b e r t y .
Knowledge of CH d e l i v e r y r a t e from t h e p i t u i t a r y g l a n d s h o u l d b e t a k e n into a c c o u n t in calculating t h e t h e r a p e u t i c regimen of CH a n d l o r GHRtI, especially d u r i n g p u b e r t y .
